Indolizine derivatives and use as cardiovascular agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4520026
SERIAL NO

06393411

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel indolizine derivatives represented by the general formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: R represents an alkyl radical having from 1 to 8 carbon atoms, or a phenyl group non-substituted or bearing one or two substituents, selected from halogen atoms and from lower alkyl and alkoxy groups, X.sub.1 represents hydrogen, chlorine, bromine, iodine, methyl or methoxy, A represents a group selected from: ##STR2## in which X.sub.2 represents hydrogen, chlorine, bromine, iodine, methyl or methoxy and X.sub.3 represents hydrogen, chlorine, bromine, iodine or methyl, R.sub.1 represents a methyl, ethyl, n-propyl or n-butyl radical, n represents an integer in the range of 2 to 6 inclusive, with the proviso that when both X.sub.2 and X.sub.3 represent hydrogen or methyl, X.sub.1 is other than hydrogen. They are effective for treating pathological syndromes of the heart and particularly angina pectoris and cardiac arrhythmias.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
S A LABAZ N V A BELGIAN COMPANYAVENUE DE BEJAR 1 BRUSSELS 1120

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Inion, Henri Wemmel, BE 13 302
Rosseels, Gilbert Wemmel, BE 6 133

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation